- Current report filing (8-K)
November 12 2009 - 8:44AM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): November 12, 2009
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
000-33009
(Commission File Number)
|
|
56-2248952
(IRS Employer Identification No.)
|
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 815-7700
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition
On November 12, 2009, MedCath Corporation (MedCath) issued a press release announcing its results
of operations for the fiscal quarter ended September 30, 2009. A copy of the press release is
furnished as Exhibit 99.1.
Included in the press release and the supplemental financial information issued by MedCath and
furnished herewith as Exhibits 99.1 and 99.2, are certain financial measures that are not generally
accepted accounting principles (non-GAAP), such as adjusted earnings before interest, taxes,
depreciation, and amortization (Adjusted EBITDA); adjusted diluted earnings per share from
continuing operations (Adjusted EPS); and Free Cash Flows. Adjusted EBITDA represents MedCaths
(loss) income from continuing operations before interest expense; loss on early extinguishment of
debt; income tax (benefit) expense; depreciation; amortization; share-based compensation expense;
loss (gain) on disposal of property, equipment and other assets; interest and other income; equity
in net earnings of unconsolidated affiliates; minority interest share of earnings of consolidated
subsidiaries; impairment of goodwill; and pre-opening expense. Adjusted EPS represents MedCaths
diluted earnings per share from continuing operations for the three months ended September 30, 2009
adjusted for third party payor adjustments, termination of management contract, impairment of
goodwill, share-based compensation expense, and pre-opening expense.
Free Cash Flows are defined as
cash flows from continuing operations less non-expansion capital expenditures. MedCaths management
uses Adjusted EBITDA to measure the performance of MedCaths various operating entities, to compare
actual results to historical and budgeted results, and to make capital allocation decisions. Free
Cash Flows are utilized by management to measure the quality of MedCaths earnings. Management
provides Adjusted EBITDA, Adjusted EPS, and Free Cash Flows to investors to assist them in
performing their analyses of MedCaths historical operating results. Further, management believes
that many investors in MedCath also invest in, or have knowledge of, other healthcare companies
that use Adjusted EBITDA, Adjusted EPS, and/or Free Cash Flows as a financial performance measure.
Because
Adjusted EBITDA, Adjusted EPS, and Free Cash Flows are non-GAAP measures, Adjusted EBITDA,
Adjusted EPS, and Free Cash Flows, as defined above, may not be comparable to other similarly titled
measures of other companies. MedCath has included a supplemental schedule with the financial
statements that accompanies this press release that reconciles historical Adjusted EBITDA to
MedCaths income from continuing operations, Adjusted EPS to diluted EPS from continuing
operations, and the computation of Free Cash Flows.
Item 9.01. Financial Statements and Exhibits
Exhibit 99.1 Press Release dated November 12, 2009
Exhibit 99.2 Financial Update dated November 12, 2009
Exhibits 99.1 and 99.2 listed in this Item 9.01 are being furnished under Item 2.02 and shall not
be deemed filed for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, nor
shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
MEDCATH CORPORATION
|
|
Date: November 12, 2009
|
By:
|
/s/ James A. Parker
|
|
|
|
James A. Parker
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
INDEX TO EXHIBITS
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
Exhibit 99.1
|
|
Press Release dated November 12, 2009
|
|
|
|
Exhibit 99.2
|
|
Financial Update dated November 12, 2009
|
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024